![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » FDA Grants Marketing Clearance to Cepheid’s Next-Generation Test for MRSA Colonization
FDA Grants Marketing Clearance to Cepheid’s Next-Generation Test for MRSA Colonization
Sunnyvale, California-based Cepheid received clearance from the FDA for Xpert MRSA NxG methicillin-resistant Staphylococcus aureus (MRSA) infection control test.
Xpert MRSA NxG is a molecular test that delivers results in about an hour.
The test has been validated for use with both ESwab (Copan) and rayon swabs. — Cynthia Jessup
Upcoming Events
-
11Jul
-
18Jul
-
21Oct